Figure 2From: Improved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS® MPH: is treatment response different between children and adolescents?Mean Children's Global Assessment Scale (C-GAS) scores. Data are presented for the overall population (n = 822) and by age subgroups (intention-to-treat, last observation carried forward). Higher scores denote improvement. Baseline to week 12 improvements were p < 0.0001 for all groups (Wilcoxon test). Assessments at week 6 are only based on data from 224 patients.Back to article page